ORIC Pharmaceuticals announced the appointment of Jacob Chacko, MD, as Chief Executive Officer. Rich Heyman, PhD, who has been serving as the interim CEO, will become Chairman of the ORIC Board of Directors. The current Chairman, Peter Svennilson, will remain on the board.

Dr. Chacko was most recently CFO of Ignyta. At Ignyta, he had a broad operational role and helped raise over $500 million in capital.